GKL-006 Combined With TACE in Treatment of Unresectable Hepatocellular Carcinoma

NCT07209813 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Beijing Gene Key Life Technology Co., Ltd